Sickle cell disease in Sri Lanka: clinical and molecular basis and the unanswered questions about disease severity-Reference-Cited by-同舟云学术

Sickle cell disease in Sri Lanka: clinical and molecular basis and the unanswered questions about disease severity

Published:2020-07-06 Issue:1 Volume:15 Page:
ISSN:1750-1172
Container-title:Orphanet Journal of Rare Diseases
language:en
Short-container-title:Orphanet J Rare Dis

Author:

Darshana Thamal^ORCID,Bandara Dayananda,Nawarathne Upul,de Silva Udaya,Costa Yasinta,Pushpakumara Kalavitigoda,Pathirage Sumithra,Basnayake Seuwandi,Epa Chamila,Dilrukshi Pradeepa,Wijayawardena Maheshaka,Anthony Angela A.,Rodrigo Rexan,Manamperi Aresha,Smith Frances,Allen Angela,Menzel Stephan,Rees David,Premawardhena Anuja

Funder

National Research Council Sri Lanka

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Genetics (clinical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13023-020-01458-w.pdf

Reference37 articles.

1. Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, et al. Sickle cell disease. Nature Reviews Disease Primers. 2018;4:18010.

2. Lanka DS-S. Census of population and housing (table A3). Sri Lanka; 2012.

3. De Silva CC, Bulugahapitiya TD, De Silva J, Wickremasinghe RL, Jonxis HP. Sinhalese family with haemoglobin S. Br Med J. 1962;1(5291):1519–21.